Literature DB >> 20405148

Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis.

Ayako Kobori1, Yuhki Yagi, Hirotsugu Imaeda, Hiromitsu Ban, Shigeki Bamba, Tomoyuki Tsujikawa, Yasuharu Saito, Yoshihide Fujiyama, Akira Andoh.   

Abstract

BACKGROUND: Interleukin (IL)-33 is a cytokine belonging to the IL-1 family. IL-33 has been shown to elicit a Th2-like cytokine response in immune cells. In this study, we investigated IL-33 expression in the inflamed mucosa of patients with inflammatory bowel disease (IBD), and characterized the molecular mechanisms responsible for IL-33 expression in human colonic subepithelial myofibroblasts (SEMFs).
METHODS: IL-33 mRNA expression was determined by real-time polymerase chain reaction (PCR). IL-33 expression in the IBD mucosa was evaluated by immunohistochemical methods.
RESULTS: IL-33 mRNA expression was significantly elevated in active lesions from patients with ulcerative colitis (UC), but was not detected in inactive lesions from UC patients or in lesions from patients with either active or inactive Crohn's disease. Colonic SEMFs were identified as a major source of IL-33 in the mucosa. IL-1β and tumor necrosis factor-α (TNF-α) significantly enhanced IL-33 mRNA and protein expression in isolated colonic SEMFs. IL-1β and TNF-α did not affect IL-33 expression in intestinal epithelial cell lines (HT-29 and Caco-2 cells). This IL-1β- and TNF-α-induced IL-33 mRNA expression was mediated by p42/44 mitogen activated protein kinase (MAPK) pathway-dependent activation of nuclear factor (NF)-κB and activator protein (AP)-1.
CONCLUSIONS: IL-33, derived from colonic SEMFs, may play an important role in the pathophysiology of UC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20405148     DOI: 10.1007/s00535-010-0245-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  30 in total

1.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

Authors:  Jochen Schmitz; Alexander Owyang; Elizabeth Oldham; Yaoli Song; Erin Murphy; Terril K McClanahan; Gerard Zurawski; Mehrdad Moshrefi; Jinzhong Qin; Xiaoxia Li; Daniel M Gorman; J Fernando Bazan; Robert A Kastelein
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

2.  Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2.

Authors:  Y R Mahida; J Beltinger; S Makh; M Göke; T Gray; D K Podolsky; C J Hawkey
Journal:  Am J Physiol       Date:  1997-12

3.  IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts.

Authors:  Kazunori Hata; Akira Andoh; Mitsue Shimada; Sanae Fujino; Shigeki Bamba; Yoshio Araki; Takafumi Okuno; Yoshihide Fujiyama; Tadao Bamba
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-06       Impact factor: 4.052

4.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors:  D Rachmilewitz
Journal:  BMJ       Date:  1989-01-14

5.  IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators.

Authors:  Mitsue Shimada; Akira Andoh; Kazunori Hata; Kazuhito Tasaki; Yoshio Araki; Yoshihide Fujiyama; Tadao Bamba
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

6.  Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells.

Authors:  H Obara; A Takayanagi; J Hirahashi; K Tanaka; G Wakabayashi; K Matsumoto; M Shimazu; N Shimizu; M Kitajima
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

7.  SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1.

Authors:  A Cuenda; J Rouse; Y N Doza; R Meier; P Cohen; T F Gallagher; P R Young; J C Lee
Journal:  FEBS Lett       Date:  1995-05-08       Impact factor: 4.124

8.  PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.

Authors:  Jing Fang; Min Ding; Lily Yang; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Cell Signal       Date:  2007-08-15       Impact factor: 4.315

9.  Activation of MAPK/AP-1 signaling pathway in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard gas analog.

Authors:  Sutapa Mukhopadhyay; Shyamali Mukherjee; Milton Smith; Salil K Das
Journal:  Toxicol Lett       Date:  2008-07-15       Impact factor: 4.372

Review 10.  The immunological and genetic basis of inflammatory bowel disease.

Authors:  Gerd Bouma; Warren Strober
Journal:  Nat Rev Immunol       Date:  2003-07       Impact factor: 53.106

View more
  110 in total

1.  Dusp5 negatively regulates IL-33-mediated eosinophil survival and function.

Authors:  Derek A Holmes; Jung-Hua Yeh; Donghong Yan; Min Xu; Andrew C Chan
Journal:  EMBO J       Date:  2014-11-14       Impact factor: 11.598

Review 2.  Interleukin-33 biology with potential insights into human diseases.

Authors:  Gaby Palmer; Cem Gabay
Journal:  Nat Rev Rheumatol       Date:  2011-04-26       Impact factor: 20.543

3.  IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function.

Authors:  Amanda Waddell; Jefferson E Vallance; Preston D Moore; Amy T Hummel; David Wu; Shiva K Shanmukhappa; Lin Fei; M Kay Washington; Phillip Minar; Lori A Coburn; Susumu Nakae; Keith T Wilson; Lee A Denson; Simon P Hogan; Michael J Rosen
Journal:  Inflamm Bowel Dis       Date:  2015-12       Impact factor: 5.325

Review 4.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

5.  IL-33 Induces Murine Intestinal Goblet Cell Differentiation Indirectly via Innate Lymphoid Cell IL-13 Secretion.

Authors:  Amanda Waddell; Jefferson E Vallance; Amy Hummel; Theresa Alenghat; Michael J Rosen
Journal:  J Immunol       Date:  2018-12-07       Impact factor: 5.422

6.  IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis.

Authors:  Carlo De Salvo; Xiao-Ming Wang; Luca Pastorelli; Benedetta Mattioli; Sara Omenetti; Kristine A Buela; Saleem Chowdhry; Rekha R Garg; Wendy A Goodman; Alex Rodriguez-Palacios; Dirk E Smith; Derek W Abbott; Fabio Cominelli; Giorgos Bamias; Wei Xin; James J Lee; Maurizio Vecchi; Theresa T Pizarro
Journal:  Am J Pathol       Date:  2016-02-22       Impact factor: 4.307

7.  IL-33 activates tumor stroma to promote intestinal polyposis.

Authors:  Rebecca L Maywald; Stephanie K Doerner; Luca Pastorelli; Carlo De Salvo; Susan M Benton; Emily P Dawson; Denise G Lanza; Nathan A Berger; Sanford D Markowitz; Heinz-Josef Lenz; Joseph H Nadeau; Theresa T Pizarro; Jason D Heaney
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

8.  CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation.

Authors:  Yang Xu; Hongxia Dong; Changhui Ge; Yan Gao; Haifeng Liu; Weiguang Li; Chenggang Zhang
Journal:  Ann Transl Med       Date:  2016-08

9.  Interleukin-33 exacerbates acute colitis via interleukin-4 in mice.

Authors:  Peter N Pushparaj; Dong Li; Mousa Komai-Koma; Rodrigo Guabiraba; James Alexander; Charles McSharry; Damo Xu
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

10.  IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling.

Authors:  Melissa Y Tjota; Jesse W Williams; Tiffany Lu; Bryan S Clay; Tiara Byrd; Cara L Hrusch; Donna C Decker; Claudia Alves de Araujo; Paul J Bryce; Anne I Sperling
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.